Akshata Korgaonkar

Akshata Korgaonkar is a Senior Scientist at Ray Therapeutics, Inc. since June 2023, previously holding positions as a Scientist I in Neuroimmunology at Alector from July 2021 to June 2023 and as a Scientist I at Tolerion, Inc. from August 2020 to July 2021. Akshata's expertise includes leading target validation studies, developing experimental strategies, and conducting pre-clinical research focused on neurological disorders. With a strong background in rodent studies and electrophysiology, Akshata has contributed to research at Washington University School of Medicine and Rutgers New Jersey Medical School, where Akshata earned a PhD in Biomedical/Medical Engineering. Early career experiences include a summer internship at Merck and a research assistant role at the Department of Veterans Affairs, complemented by foundational education in Biomedical Engineering from Mumbai University.